TZDs can decrease the insulin resistance, modify the adipocyte differentiation [30], inhibit the VEGF-induced angiogenesis [31], decrease leptin levels (perhaps leading to an increased appetite) and have the effects of anti-inflammatory. The gene discussed is VEGFA; the disease is Insulin resistance.